2023-11-12T16:01:42-06:00 2022-12-31 Foundation Source 3333 New Hyde Park Rd Ste 406 New Hyde Park NY 11042 990PF 2022-01-01 454797578 David & Janet Polak Foundation % Foundation Source DAVI 8008391754 Foundation Source 501 Silverside Rd Wilmington DE 198091377 Jeffrey Polak President 8008391754 2023-11-07 true Jeffrey Polak 999009999 Jeffrey D Haskell P01345770 8008391754 2022 2023-04-26 12:10:37Z X 80733214 X 0 X 87745 87745 810321 810321 3459673 49486786 3376604 883610 951901 5241349 5226571 247768 247768 74000 74000 44042 44042 17923 0 0 17923 561570 409834 151736 1006 1006 161872 17659 71319 71319 205881 205881 9483 9483 809768 678386 105556 2204632 1106885 0 927708 2654600 2654600 4859232 1106885 0 3582308 382117 4119686 5727416 4714004 4714004 25956247 26201842 26302681 11487851 12232803 14336017 1000149 1000149 818390 22141023 22047005 30033861 4150100 4650100 4528261 70462786 70845903 80733214 0 0 X 70462786 70845903 70462786 70845903 70462786 70845903 70462786 382117 1000 70845903 70845903 Publicly-traded Securities 49486786 47470162 2016624 2016624 Passthrough K1 Capital Gain/(Loss) 1304675 DISTRIBUTIONS IN EXCESS OF BASIS 55305 3376604 57264 57264 57264 56430 0 13100 69530 X 0 12266 12266 false false false false false true true false true true CA DE true false false false false true Foundation Source 8008391754 501 Silverside Road Suite 123 Wilmington DE 198091377 false false false true true false false false false false false false false false false false true false false true false false false false David Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Janet Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Jeff Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir, Pres, Executive Dir 40.0 247768 11000 0 Robert Polak Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Jonathan Seltzer Foundation Source 501 Silverside Rd Wilmington DE 198091377 Dir 1.0 0 0 0 Noreen L Rubio 3850 N WILKE RD ARLINGTON HEIGHTS IL 60004 ADMINISTRATIVE ASST 40.0 74000 Polak Investors LLC 1880 Century Park East Suite 811 Los Angeles CA 90067 Investment Mgmt 394893 POP 403 Productions LLC 15057 Greenleaf Street Sherman Oaks CA 91403 Philanthropic 115873 Foundation Source 55 Walls Drive 3rd Fl Fairfield CT 06824 Administrative 93698 AKLA PROGRAM - WILL INTRODUCE PARTICIPANTS TO EXCITING & INSPIRING NEW WAYS OF LOOKING AT THEIR JEWISH VALUES & CONNECT THEM WITHIN THEIR OWN LIVES & LA JEWISH COMMUNITY 321880 YAMO PHARMACEUTICALS LLC - TO PROMOTE HEALTH BY FINDING AN EFFECTIVE CURE FOR AUTISM 250000 NEUROVISION IMAGING INC - TO PROMOTE HEALTH AND REDUCE SUFFERING OF THOSE AFFECTED WITH NEUROGENERATIVE CONDITIONS INCLUDING ALZHEIMERS 250000 500000 42432240 6405475 30067976 78905691 0 78905691 1183585 77722106 3886105 3886105 57264 4150 61414 3824691 1000 3825691 3825691 3582308 500000 0 0 0 4082308 3825691 3858101 2020 2019 2018 4082308 3858101 224207 0 0 3601484 0 0 NONE X AMCHA INITIATIVE 517 BETHANY CURVE SANTA CRUZ CA 95060 N/A PC General & Unrestricted 20000 AMERICAN FRIENDS OF ISRAELI NAVY SEALS INC 138 W 133RD ST NEW YORK NY 10030 N/A PC funds for Three scholarships each be "repaid" with 120 hours of community service to impactful partner organizations;(800 NIS) Passover gift vouchers for Israel Navy SEAL unit soldiers in financial need 15100 AMERICAN FRIENDS OF SHEBA MEDICAL CENTER INC 6505 WILSHIRE BLVD STE 615 LOS ANGELES CA 90048 N/A PC General & Unrestricted 10000 AMERICAN FRIENDS OF THE ISRAEL MUSEUM 545 5TH AVE RM 920 NEW YORK NY 10017 N/A PC General & Unrestricted 5000 AMERICAN FRIENDS OF THE ISRAEL PHILHARMONIC ORCHES 555 W 5TH ST 35TH FL LOS ANGELES CA 90013 N/A PC General & Unrestricted 10000 AMERICAN SOCIETY FOR TECHNION- ISRAEL INSTITUTE OF 55 EAST 59TH ST 14TH FLOOR NEW YORK NY 10022 N/A PC General & Unrestricted 10000 AMERICAN YOUTH SYMPHONY INC 841 APOLLO ST STE 344 EL SEGUNDO CA 90245 N/A PC General & Unrestricted 5000 AMERICANS FOR BEN-GURION UNIVERSITY INC 1001 AVE OF THE AMERICAS FL 19 NEW YORK NY 10018 N/A PC Israel's National Artificial Intelligence Resilience Laboratory 800000 AMERICANS FOR BEN-GURION UNIVERSITY INC 1001 AVE OF THE AMERICAS FL 19 NEW YORK NY 10018 N/A PC General & Unrestricted 2500 AYN RAND INSTITUTE THE CENTER FOR THE ADVANCEMENT 6 HUTTON CENTRE DR STE 600 SANTA ANA CA 92707 N/A PC General & Unrestricted 30000 AYN RAND INSTITUTE THE CENTER FOR THE ADVANCEMENT 6 HUTTON CENTRE DR STE 600 SANTA ANA CA 92707 N/A PC Free Books Program for Teachers in Los Angeles County 25000 BAYIT SHELANU SYNAGOGUE 10825 ASHBY AVE LOS ANGELES CA 90064 N/A PC General & Unrestricted 1800 BEIT TSHUVAH 8831 VENICE BLVD LOS ANGELES CA 90034 N/A PC General & Unrestricted 5000 BUCKLEY SCHOOL 3900 STANSBURY AVE SHERMAN OAKS CA 91423 N/A PC General & Unrestricted 10000 CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD W HOLLYWOOD CA 90048 N/A PC Board of Governors Innovation Center 100000 CEDARS-SINAI MEDICAL CENTER 8700 BEVERLY BLVD W HOLLYWOOD CA 90048 N/A PC General & Unrestricted 25000 CENTRAL FUND OF ISRAEL 461 CENTRAL AVE CEDARHURST NY 11516 N/A PC General & Unrestricted 35000 COMMITTEE FOR ACCURACY IN MIDDLE EAST REPORTING IN PO BOX 35040 BOSTON MA 02135 N/A PC General & Unrestricted 20000 CONCERN FOUNDATION 11111 W OLYMPIC BLVD STE 214 LOS ANGELES CA 90064 N/A PC General & Unrestricted 6000 CROHN'S & COLITIS FOUNDATION OF AMERICA - THE GREA 10350 SANTA MONICA BLVD STE 120 LOS ANGELES CA 90025 N/A PC General & Unrestricted 10000 CUFI CHURCH ASSOCIATION PO BOX 1307 SAN ANTONIO TX 78295 N/A PC General & Unrestricted 10000 DAVID HOROWITZ FREEDOM CENTER 28494 WESTINGHOUSE PL STE 212 VALENCIA CA 91355 N/A PC General & Unrestricted 15000 ENDOWMENT FOR MIDDLE EAST TRUTH 700 STONINGTON RD SILVER SPRING MD 20902 N/A PC General & Unrestricted 20000 FOUNDATION FOR ECONOMIC EDUCATION INC 1819 PEACHTREE RD NE STE 300 ATLANTA GA 30309 N/A PC General & Unrestricted 5000 FOUNDATION FOR INDIVIDUAL RIGHTS AND EXPRESSION IN 510 WALNUT ST STE 1250 PHILADELPHIA PA 19106 N/A PC General & Unrestricted 5000 FRIENDS OF ELNET 5215 OLD ORCHARD RD STE 880 SKOKIE IL 60077 N/A PC General & Unrestricted 100000 FRIENDS OF ISRAEL SCI-TECH SCHOOLS INC 477 MADISON AVE 6TH FL NEW YORK NY 10022 N/A PC General & Unrestricted 5000 FRIENDS OF THE ISRAEL DEFENSE FORCES - LOS ANGELES 6505 WILSHIRE BLVD STE 625 LOS ANGELES CA 90048 N/A PC sponsor 13 additional IMPACT! Scholarship students 52000 HAROLD GRINSPOON FOUNDATION 67 HUNT ST STE 100 AGAWAM MA 01001 N/A SO I PJ Library fund 15000 HILLSDALE COLLEGE 33 E COLLEGE ST HILLSDALE MI 49242 N/A PC General & Unrestricted 10000 HONEST REPORTING COM INC 165 E 56TH ST 2ND FL NEW YORK NY 10022 N/A PC General & Unrestricted 10000 IMAGINATION PRODUCTIONS INC 11110 W OAKLAND PARK BLVD STE 288 SUNRISE FL 33351 N/A PC Initial research phase for film project 25000 IMAGINATION PRODUCTIONS INC 11110 W OAKLAND PARK BLVD STE 288 SUNRISE FL 33351 N/A PC General & Unrestricted 10000 IMERMAN ANGELS 2001 N HALSTED ST STE 302 CHICAGO IL 60614 N/A PC General & Unrestricted 5000 ISRAEL CANCER RESEARCH FUND INC 52 VANDERBILT AVE S1510 NEW YORK NY 10017 N/A PC Research Career Development Program 49500 ISRAEL EMERGENCY ALLIANCE - STANDWITHUS PO BOX 341069 LOS ANGELES CA 90034 N/A PC General & Unrestricted 200000 ISRAEL TENNIS CENTERS FOUNDATION INC 165 E 56TH ST 2ND FL NEW YORK NY 10022 N/A PC General & Unrestricted 5000 JEWBELONG INC 45 AFTERGLOW WAY VERONA NJ 07044 N/A PC General & Unrestricted 5000 JEWISH FEDERATION COUNCIL OF GREATER LOS ANGELES 6505 WILSHIRE BLVD STE 800 LOS ANGELES CA 90048 N/A PC PJ Library fund in Los Angeles 18000 JEWISH FEDERATION COUNCIL OF GREATER LOS ANGELES 6505 WILSHIRE BLVD STE 800 LOS ANGELES CA 90048 N/A PC expanding the Community Security Initiative (CSI) through the new CSI Public Outreach Program 75000 JEWISH FEDERATION COUNCIL OF GREATER LOS ANGELES 6505 WILSHIRE BLVD STE 800 LOS ANGELES CA 90048 N/A PC General & Unrestricted 140000 JEWISH FUNDERS NETWORK 150 W 30TH ST RM 900 NEW YORK NY 10001 N/A PC General & Unrestricted 3600 JEWISH NEWS SERVICE INC 40 NONANTUM ST NEWTON MA 02458 N/A PC General & Unrestricted 10000 JEWISH WOMENS THEATRE 3435 OCEAN PARK BLVD STE 107 PMB 85 SANTA MONICA CA 90405 N/A PC General & Unrestricted 2500 LAWFARE PROJECT INC 633 THIRD AVE 21ST FLOOR NEW YORK NY 10017 N/A PC General & Unrestricted 25000 LOS ANGELES JEWISH HOME FOR THE AGING 7150 TAMPA AVE RESEDA CA 91335 N/A PC General & Unrestricted 25000 LOS ANGELES PHILHARMONIC ASSOCIATION 151 S GRAND AVE LOS ANGELES CA 90012 N/A PC General & Unrestricted 5000 LOS ANGELES SHERIFFS FOUNDATION 10960 WILSHIRE BLVD 5TH FL LOS ANGELES CA 90024 N/A PC General & Unrestricted 5000 MANHATTAN INSTITUTE FOR POLICY RESEARCH INC 52 VANDERBILT AVE NEW YORK NY 10017 N/A PC General & Unrestricted 5000 MASSACHUSETTS INSTITUTE OF TECHNOLOGY 600 MEMORIAL DR BLDG W98-300 CAMBRIDGE MA 02139 N/A PC MISTI MIT-Israel fund to support student internships 40000 MIDDLE EAST FORUM 1650 MARKET ST STE 3600 PHILADELPHIA PA 19103 N/A PC to fund approximately 10 percent of annual Israel Victory Project 40000 MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC PO BOX 27837 WASHINGTON DC 20038 N/A PC General & Unrestricted 5000 MOISHE HOUSE 441 SAXONY RD BARN 2 ENCINITAS CA 92024 N/A PC funds for Sherman Oaks and the other LA Moishe Houses 50000 MUSEUM ASSOCIATES 5905 WILSHIRE BLVD LOS ANGELES CA 90036 N/A PC General & Unrestricted 5000 PACIFIC LEGAL FOUNDATION 555 CAPITOL MALL STE 1290 SACRAMENTO CA 95814 N/A PC General & Unrestricted 5000 PARDES INSTITUTE OF JEWISH STUDIES NORTH AMERICA I 54 W 40TH ST NEW YORK NY 10018 N/A PC General & Unrestricted 5000 PRAGER UNIVERSITY FOUNDATION 15021 VENTURA BLVD 552 SHERMAN OAKS CA 91403 N/A PC General & Unrestricted 50000 PROCLAIMING JUSTICE TO THE NATIONS INC PO BOX 682711 FRANKLIN TN 37068 N/A PC General & Unrestricted 20000 REMEMBER US THE HOLOCAUST BNAI MITZVAH PROJECT 1112 MONTANA AVE 182 SANTA MONICA CA 90403 N/A PC General & Unrestricted 3600 REPORT INC - RESEARCH EVALUATION PROMOTING OR PMB 225 1121 N BETHLEHEM PIKE STE 6 SPRING HOUSE PA 19477 N/A PC General & Unrestricted 50000 ROAD RUNNERS CLUB OF AMERICA 9854 NATIONAL BLVD 534 LOS ANGELES CA 90034 N/A PC Track Permits program 5000 SIMON WIESENTHAL CENTER INC 1399 S ROXBURY 2ND FL LOS ANGELES CA 90035 N/A PC Moriah Films' comprehensive documentary about the life and legacy of David Ben-Gurion 70000 STUDENTS RUN AMERICA 5252 CREBS AVE TARZANA CA 91356 N/A PC General & Unrestricted 5000 THE JEWISH INSTITUTE FOR NATIONAL SECURITY OF AMER 1101 14TH ST NW STE 1030 WASHINGTON DC 20005 N/A PC General & Unrestricted 100000 THE MAPLE COUNSELING CENTER 439 N CANON DR STE 209 BEVERLY HILLS CA 90210 N/A PC General & Unrestricted 5000 THE OPEN TEMPLE 1422 ELECTRIC AVE VENICE CA 90291 N/A PC General & Unrestricted 5000 TRIBE MEDIA CORP 1800 CENTURY PARK E STE 200 LOS ANGELES CA 90067 N/A PC General & Unrestricted 75000 TURNING POINT USA INC 4940 EAST BEVERLY RD PHOENIX AZ 85044 N/A PC Jewish Programs in the 2022-2023 academic year 25000 UNITED STATES HOLOCAUST MEMORIAL MUSEUM 100 RAOUL WALLENBERG PL SW WASHINGTON DC 20024 N/A PC General & Unrestricted 5000 UNIVERSITY OF SOUTHERN CALIFORNIA 3551 TROUSDALE PKWY ADM 160 LOS ANGELES CA 90089 N/A PC Furthering the mission of the "USC Center for the Political Future" 50000 WASHINGTON INSTITUTE FOR NEAR EAST POLICY 1111 19TH ST NW STE 500 WASHINGTON DC 20036 N/A PC General & Unrestricted 5000 YOUNG AMERICA'S FOUNDATION 11480 COMMERCE PARK DR STE 600 RESTON VA 20191 N/A PC to sponsor 10 students to our 2023 High School conferences at the Reagan Ranch 25000 2654600 14 87745 14 810321 525990 278967 18 3180706 K-1 Inc/Loss 525990 -223920 14 953155 Federal Tax Refund 01 117578 STATE TAX REFUND 01 38051 FOREIGN CURRENCY LOSS 01 -1254 55047 5186302 5241349 false false false false false false false false false false Jeff Polak * DAVID POLAK (DIRECTOR), JANET POLAK (DIRECTOR) AND JEFF POLAK PRESIDENT/DIRECTOR/EXECUTIVE DIRECTOR), OF DAVID & JANET POLAK FOUNDATION (THE "FOUNDATION"), ARE PRINCIPALS AT THE INVESTMENT MANAGEMENT FIRM POLAK INVESTORS, LLC, A DISQUALIFIED PERSON WHICH PROVIDES INVESTMENT MANAGEMENT SERVICES TO THE FOUNDATION. IN THE TAXABLE YEAR ENDING DECEMBER 31, 2022, THE FOUNDATION PAID $394,893 FOR INVESTMENT MANAGEMENT SERVICES RENDERED BY SUCH DISQUALIFIED PERSON, AS REPORTED IN PART I, LINE 16C. THE REASONABLENESS OF THE PROFESSIONAL FEES WAS ESTABLISHED BY AN OUTSIDE COMPENSATION COMMITTEE, WHICH REVIEWED THE RATES CHARGED BY COMPARABLE INVESTMENT MANAGEMENT FIRMS. NEUROVISION IMAGING INC 1395 GARDEN HIGHWAY SUITE 250 SACRAMENTO CA 95833 2014-12-17 250000 PRI INVEST-SEE GEN EXPLAN FOR PURPOSE & ADDTL DETAILS RE AMT, AMT EXPENDED, & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. BRUIN BIOMETRICS LLC 10960 WILSHIRE BLVD SUITE 950 LOS ANGELES CA 90024 2015-05-13 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. BIOP MEDICAL LTD 10 Ohaliav St RAMAT GAN IS 5252263 2017-04-21 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. ONLINE DISRUPTIVE TECHNOLOGIES INC MATAM ADV TECH PK BLD 23 POBX 15050 HAIFA IS 3190501 2017-04-21 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. ORGENESIS LTD ARAD STREET 9 TEL AVIV IS 2017-04-21 305498 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. BRYN PHARMA LLC FKA EPI-NOW LLC 518 NORTH HILLCREST ROAD BEVERLY HILLS CA 90210 2018-07-13 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. CYWAT TECHNOLOGIES LTD 168 JABOTINSKY ST BNEI BRAK IS 2018-11-26 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. BIO-ACTIVES SYNERYGIO LTD FKA YB MO CHO HITECH VIL 4/9 GIVAT RAM POB 39231 JERUSALEM IS 9129102 2018-04-20 250000 PRI LOAN-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. BIO-ACTIVES SYNERYGIO LTD FKA YB MO CHO HITECH VIL 4/9 GIVAT RAM POB 39231 JERUSALEM IS 9129102 2018-07-19 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. MAXQ AI LTD 96 YIGAL ALON STREET ENTRANCE A TEL AVIV IS 6789140 2019-03-19 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. EXTHERA MEDICAL CORPORATION 757 ARNOLD DRIVE SUITE B MARTINEZ CA 94553 2019-12-19 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. YONALINK LTD HADASSAH EIN KEREM HOSP POB 12000 JERUSALEM IS 9112001 2019-11-12 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. AMICROBE INC 3142 TIGER RUN COURT 103 CARLSBAD CA 92010 2019-10-31 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. OCTHEALTH LLC 1395 GARDEN HIGHWAY SUITE 250 SACRAMENTO CA 95833 2021-06-08 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. BIO-ACTIVES SYNERGIO LTD HI-TECH VILLAGE UNIT 4/9 POB39231 GIVAT RAM IS 9129102 2021-10-12 100000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. CYWAT TECHNOLOGIES LTD 168 JABOTINSKY ST BNEI BRAK IS 2021-06-15 100000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORTS WERE MADE. NEUROVISION IMAGING INC 1395 Garden Highway Suite 250 sacramento CA 95833 2022-06-17 250000 PRI LOAN-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. YAMO PHARMACEUTICALS LLC 400 Madison Ave Ste 11A NEW YORK NY 10017 2022-07-13 250000 PRI INVEST-SEE GENERAL EXPLANATION FOR PURPOSE & ADDTL DETAILS RE AMT EXPENDED & LACK OF DIVERSION NO See General Explanation for Report Dates THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: NEUROVISION IMAGING, INC. DATES AND AMOUNTS OF PRI: 12/17/2014 $250,000 5/17/2018 $37,502 PURPOSE OF PRI: RESEARCH AND DEVELOPMENT OF DIAGNOSTIC TOOLS FOR EARLY-STAGE DETECTION OF ALZHEIMER'S DISEASE AND OTHER DEGENERATIVE NEUROLOGICAL DISORDERS. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 3/25/2015 FOR FYE 12/31/2014 DATE OF REPORT: 5/18/2016 FOR FYE 12/31/2015 DATE OF REPORT: 6/7/2017 FOR FYE 12/31/2016 DATE OF REPORT: 5/11/2018 FOR FYE 12/31/2017 DATE OF REPORT: 11/1/2019 FOR FYE 12/31/2018 DATE OF REPORT: 6/2/2020 FOR FYE 12/31/2019 DATE OF REPORT: 6/28/2021 FOR FYE 12/31/2020 DATE OF REPORT: 8/25/2023 FOR FYE 12/31/2021 DATE OF REPORT: 8/25/2023 FOR FYE 12/31/2022 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BRUIN BIOMETRICS, LLC DATE AND AMOUNT OF PRI: 5/13/2015 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY EARLY-STAGE PRESSURE ULCERS DURING THEIR HOSPITAL STAYS AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 5/24/2016 FOR FYE 12/31/2015 DATE OF REPORT: 6/29/2017 FOR FYE 12/31/2016 DATE OF REPORT: 5/15/2018 FOR FYE 12/31/2017 DATE OF REPORT: 6/14/2019 FOR FYE 12/31/2018 DATE OF REPORT: 4/22/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/25/2022 FOR FYE 12/31/2020 DATE OF REPORT: 8/11/2022 FOR FYE 12/31/2021 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BIOP MEDICAL LTD DATES AND AMOUNTS OF PRI: 4/21/2017 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY DISEASE AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/4/2018 FOR FYE 12/31/2017 DATE OF REPORT: 2/12/2019 FOR FYE 12/31/2018 DATE OF REPORT: 11/13/2021 FOR FYE 12/31/2019 DATE OF REPORT: 11/13/2021 FOR FYE 12/31/2020 Although the foundation has made multiple attempts to obtain formal reports for 2021 and 2022, it has been unable to do so. However, BIOP has informally indicated that it has neither funds available nor working staff, and that its activities have been reduced to the bare minimum from the onset of the pandemic and have not since recovered. Per Section 53.4945-5(e)(2) of the Treasury Regulations, the failure of PRI Recipient to submit an annual report will not result in a taxable expenditure for the Foundation because the Foundation (i) made the grant in accordance with paragraph (b) of said section of the Regulations, (ii) has complied with the reporting requirements contained in paragraph (d) of said section of the Regulations, (iii) made a reasonable effort to obtain the required report, and (iv) will withhold all future payments on any grant to this grantee until such report is furnished. THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: ONLINE DISRUPTIVE TECHNOLOGIES, INC. DATE AND AMOUNT OF PRI: 4/21/2017 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY CANCER AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/6/2018 FOR FYE 12/31/2017 DATE OF REPORT: 2/12/2019 FOR FYE 12/31/2018 DATE OF REPORT: 6/1/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/18/2021 FOR FYE 12/31/2020 DATE OF REPORT: 3/20/2023 FOR FYE 12/31/2021 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BRYN PHARMA LLC F/K/A EPI-NOW LLC DATE AND AMOUNT OF PRI: 7/13/2018 $250,000 PURPOSE OF PRI: TO PROMOTE THE HEALTH OF THOSE WHO REQUIRE EPINEPHRINE AND TO ADVANCE SCIENTIFIC UNDERSTANDING THROUGH RESEARCH IN THE PUBLIC INTEREST. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 8/23/2019 FOR FYE 12/31/2018 DATE OF REPORT: 10/24/2020 FOR FYE 12/31/2019 DATE OF REPORT: 8/2/2021 FOR FYE 12/21/2020 DATE OF REPORT: 5/16/2023 FOR FYE 12/21/2021 DATE OF REPORT: 4/25/2023 FOR FYE 12/21/2022 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. APPRECIATION OF PROPERTY. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: ORGENESIS LTD. DATE AND AMOUNT OF PRI: 4/21/2017 $305,498 PURPOSE OF PRI: TO PROMOTE THE HEALTH AND REDUCE THE SUFFERING OF THOSE AFFECTED BY DIABETES BY WAY OF RESEARCHING AND BRINGING TO CLINICAL TRIAL THE COMPANY TECHNOLOGY SOLUTION. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED FULL AND COMPLETE FINANCIAL REPORTS OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 9/9/2018 FOR FYE 12/31/2017 DATE OF REPORT: 10/20/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/20/2020 FOR FYE 12/31/2019 DATE OF REPORT: 5/20/2021 FOR FYE 12/31/2020 DATE OF REPORT: 5/14/2023 FOR FYE 12/31/2021 DATE OF REPORT: 5/14/2023 FOR FYE 12/31/2022 THE FOUNDATION EXERCISED AN OPTION TO EXCHANGE ITS INTEREST IN THE INVESTEE FOR THE STOCK IN THE PARENT COMPANY OF THE INVESTED. THIS WAS DONE TO PRESERVE THE PRI AND NOT TO GENERATE INCOME OR FOR THE APPRECIATION OF PROPERTY. THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: CYWAT TECHNOLOGIES LTD DATES AND AMOUNTS OF PRI: 11/26/2018 $250,000 3/3/2021 $7,101 PURPOSE OF PRI: TO PROMOTE THE HEALTH OF PEOPLE WHO ARE AFFECTED BY POLLUTED DRINKING WATER BY FUNDING THE DEVELOPMENT OF A WATER MONITORING SYSTEM THAT IS DISTRIBUTED THROUGHOUT THE ENTIRE WATER GRID AND WHICH CAN IMMEDIATELY DETECT POTENTIAL DANGERS. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 6/18/2019 FOR FYE 12/31/2018 DATE OF REPORT: 1/13/2020 FOR FYE 12/31/2019 DATE OF REPORT: 1/20/2022 FOR FYE 12/31/2020 DATE OF REPORT: 1/16/2022 FOR FYE 12/31/2021 DATE OF REPORT: 6/13/2023 FOR FYE 12/31/2022 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BIO-ACTIVES SYNERGIO LTD. F/K/A Y&B MOTHERS CHOICE LTD. DATE AND AMOUNT OF PRI: 4/20/2018 $250,000 PURPOSE OF PRI: TO PROMOTE HEALTH BY FUNDING RESEARCH INTO DEVELOPING NON HAZARDOUS, NATURAL PRODUCTS THAT DO NOT ENDANGER HUMAN HEALTH. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2019 DATE OF REPORT: 11/13/2022 FOR FYE 12/31/2020 DATE OF REPORT: 9/18/2023 FOR FYE 12/31/2021 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: BIO-ACTIVES SYNERGIO LTD. F/K/A Y&B MOTHERS CHOICE LTD. DATE AND AMOUNT OF PRI: 7/19/2018 $250,000 PURPOSE OF PRI: TO PROMOTE HEALTH BY FUNDING RESEARCH INTO DEVELOPING NON HAZARDOUS, NATURAL PRODUCTS THAT DO NOT ENDANGER HUMAN HEALTH. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2018 DATE OF REPORT: 10/29/2020 FOR FYE 12/31/2019 DATE OF REPORT: 11/13/2022 FOR FYE 12/31/2020 DATE OF REPORT: 9/18/2023 FOR FYE 12/31/2021 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY FORM 990-PF, PART VI-B, LINE 5D - EXPENDITURE RESPONSIBILITY PRI RECIPIENT: MAXQ AI, LTD DATE OF PRI: 3/19/2019 $250,000 PURPOSE OF PRI: TO PROMOTE THE DEVELOPMENT OF A PRODUCT THAT WILL SUBSTANTIALLY BENEFIT THE PUBLIC BY INCORPORATING SOPHISTICATED ARTIFICIAL INTELLIGENCE INTO DIAGNOSTIC RADIOLOGY. REPORTS OF AMOUNTS EXPENDED: RECIPIENT HAS SUBMITTED A FULL AND COMPLETE FINANCIAL REPORT OF THE TYPE ORDINARILY REQUIRED BY COMMERCIAL INVESTORS UNDER SIMILAR CIRCUMSTANCES AND A STATEMENT THAT IT HAS COMPLIED WITH THE TERMS OF THE INVESTMENT FOR ITS FISCAL YEARS INDICATED BELOW: DATE OF REPORT: 10/13/2020 FOR FYE 12/31/2019 DATE OF REPORT: 7/20/2021 FOR FYE 12/31/2020 DATE OF REPORT: 3/24/2023 FOR FYE 12/31/2021 DATE OF REPORT: 7/7/2023 FOR FYE 12/31/2022 THIS INVESTMENT REMAINED ON THE FOUNDATION'S BOOKS AS OF 12/31/2022. DIVERSIONS: TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED TO ANY ACTIVITY OTHER THAN THE ACTIVITY FOR WHICH THE INVESTMENT WAS ORIGINALLY MADE. EDISON INTL BOND PERPETUAL - 5 1000149 818390 AGNICO EAGLE MINES LTD 735250 816503 AMERICAN AXLE & MFG HOLDINGS I 263446 204102 ARCH COAL, INC 84323 142790 ARDAGH METAL PACKAGING SA 76117 48100 B2 GOLD CORP COM NPV 150587 150654 BARRICK GOLD CORPORATION 757500 429500 BAYER A G SPONSORED ADR 198370 102880 BERRY PLASTICS GROUP INC 274208 362580 BLOOM ENERGY CORP 19368 19120 BP PLC SPONSORED ADR 102249 104790 CAMECO CORPORATION 19784 22670 CENTERRA GOLD INC 88332 51800 CENTURY ALUMINUM COMPANY 134168 81800 CHENIERE ENERGY INC 262699 524860 CITIGROUP INC 248049 226150 CLIFFS NATURAL RESOURCES INC. 94101 96660 COMPASS MINERALS INTERNATIONAL 82086 82000 COMSTOCK RES INC 139670 287910 CONSOL ENERGY, INC 177409 390000 CONSTELLIUM NV 136767 70980 COPPER MOUNTAIN MINI NG CORP 66822 151200 COTERRA ENERGY INC 425563 590024 CVS CAREMARK CORP 466000 931900 DANA HOLDING CP 137340 121040 ELDORADO GOLD CORP COM NPV 308509 234080 ENDEAVOUR MINING CORP 206264 213907 FIDELITY CONSERV INC BD FD 8731 8694 FIRST MAJESTIC SILVER CORP 109720 83400 FIRST QUANTUM MINERALS LTD 17953 41720 FLUTTER ENTERTAINMENT ORD SHS 90356 94325 GENERAL MOTORS 361740 336400 GOLD FIELDS LTD ADS 140581 269100 GRAFTECH INTERNATIONAL LTD 391515 166600 GRAPHIC PACKAGING CORP COM STK 41828 66750 HALLIBURTON COMPANY 226736 236100 HESS CORP 190621 283640 HOLCIM LTD SPON ADS 57245 102900 HOLCIM N 491587 517510 HUDBAY MINERALS INC 186121 152100 IVANHOE MINES LTD 60260 237000 JAPAN SMALLER CAPITALIZATION F 403984 329184 JET2 PLC 78926 115286 JOHNSON & JOHNSON 231728 441625 KAZATOMPROM JSC NAC GDR 147503 281400 MARKET VECTORS VIETNAM ETF 40705 23680 MERCK & CO INC 226844 554750 MICRON TECHNOLOGY 300822 549780 NEWCREST MINING LTD 109012 134830 NEWMONT GOLDCORP CORPORATION 574088 748403 NEXGEN ENERGY LTD 115963 155050 NOVAGOLD RESOURCES 108485 119600 NUVEEN MLT STR I&G 9760 7280 OCEANAGOLD CORPORATION COM 142250 114000 ORGANON & CO 18170 22344 PEABODY ENERGY CORP 111551 132100 PFIZER INC 294452 614880 PHILIP MORRIS INTL 8916 10121 SHELL ADR EACH REPRESENTING 2 202042 227800 TEVA PHARMACEUTICAL INDUSTRIES 36513 9120 THE MOSAIC CO 306123 350960 TOREX GOLD RESOURCES 181332 172500 TPG RE FINANCE TRUST INC 2013 679 TRUIST FINANCIAL CORPORATION 30848 43030 UNITED STATES STEEL CORP 48470 50100 VALARIS LTD WTS EXP 04/29/2028 220170 1142 VALARIS PLC COM CL A 161969 VIATRIS ORD SHS 90189 72134 23699318 23846633 2502524 2456048 AIR U.S. LIFE FUND III, LP 2091530 2156858 AIR US LIFE FUND IV, LP 1996407 2149384 ALPHA WAVE (F/K/A FALCON EDGE) 551806 1332337 ALTAIR - PACIFIC COAST CPTL PT 467684 365083 ALTAIR DIRECT LENDING FUND, LL 166151 149222 ALTAIR EUROPEAN R E OPPORTUNIT 659098 226593 ALTAIR SENIOR HOUSING FUND (AE 49830 451866 ANAGENESIS CAPITAL PARTNERS SB 1247114 2139296 ASM CONNAUGHT HOUSE FUND III L 1000000 1278344 AVANTE CAPITAL PARTNERS SBIC I 229509 234765 BROAD ST REAL ESTATE CREDIT PT 139481 BW GAS & CONVENIENCE ONSHORE F 1 3040428 DORCHESTER CAPITAL SECONDARIES 810630 1063452 ENLIGHTENMENT CAP SOLUTION III 1385602 3163935 ENLIGHTENMENT CAP SOLUTION IV 440192 449928 FIRST EAGLE CLO EQUITY FUND I, 280004 176406 FOURTHSTONE SMALL-CAP FINANCIA 353864 414152 GOLDMAN SACHS VINTAGE FUND V L 302066 82615 GRANITE CREEK FLEXCAP II, L.P 1030020 1113908 GS DISTRESSED OPPORTUNITIES FU 133187 135718 GSO CAPITAL SOLUTIONS FD II 1 6008 2678 GSO CAPITAL SOLUTIONS FD II 2 77804 26952 GSO CAPITAL SOLUTIONS FD II LP 266762 118905 GSO ENERGY SELECT OPP FD AIV-2 74433 86351 GSO ENERGY SELECT OPP FD AIV-3 57108 53389 GSO ENERGY SELECT OPP FD AIV-5 1287 1203 GSO ENERGY SELECT OPP FUND 14932 13400 LATITUDE MGMT RE CAP III 40000 22479 LATITUDE MGMT RE CAP IV 2000000 2022277 PCCP EQUITY VII, LP 1818674 2812522 PCCP EQUITY VIII, LP 685393 933217 QS CAPITAL STRATEGIES II, L.P 686664 713701 SILVERVIEW CREDIT OPP FUND LP 55573 90230 SILVERVIEW CREDIT OPP OFFSHORE 1300213 1300213 THE EDGBASTON ASIAN EQUITY TRU 1421237 1226351 BERNIE L MADOFF - CLAIM RECEIV 346222 346222 Document Review/Drafting 12453 12453 General Consultations 5470 5470 PRI - AMICROBE, INC 250000 250000 PRI - BARAK BALLET 200000 200000 PRI - BIOP MEDICAL 250000 250000 PRI - BRUIN_BIOMETRICS 250000 250000 PRI - BRYN PHARMA LLC F/K/A EP 250000 250000 PRI - CYWAT TECH 507100 507101 PRI - EXTHERA MEDICAL CORP 250000 250000 PRI - MAXQ AI, LTD 250000 250000 PRI - MOTHERS CHOICE 250000 250000 PRI - MOTHERS CHOICE (2) 250000 250000 PRI - NEUROVISION IMAGING, INC 250000 250000 PRI - OCTHEALTH LLC - 15,000 U 250000 250000 PRI - ONLINE DISRUPTIVE 250000 250000 PRI - ORGENESIS - 32,052 SHARE 294398 183658 PRI - ORGENESIS WTS - 32,052 U 11100 PRI - SER A1 PFD (82,175 UNITS 250000 250000 PRI - SER A2 PFD (15,408 UNITS 37502 37502 PRI - SYNERGIO BIO ACTIVES LTD 100000 100000 PRI - YAMO PHARMACEUTICALS LLC 250000 250000 PRI - YONALINK LTD 250000 250000 Administrative Fees 93698 93698 Bank Charges 1091 1091 Cell Phone Expense 822 822 Insurance Premiums 1129 1129 K-1 Exp AIR U.S. LIFE FUND III 131124 131124 K-1 Exp AIR US LIFE FUND IV, L 84930 84930 K-1 Exp ALPHA WAVE (F/K/A FALC 7931 7931 K-1 Exp ALTAIR - PACIFIC COAST 12873 12871 K-1 Exp ALTAIR DIRECT LENDING 1057 1047 K-1 Exp ALTAIR SENIOR HOUSING 3259 3209 K-1 Exp ANAGENESIS CAPITAL PAR 152411 151900 K-1 Exp AVANTE CAPITAL PARTNER 56039 50467 K-1 Exp BW GAS & CONVENIENCE O 434 172 K-1 Exp ENLIGHTENMENT CAPITAL 50232 50145 K-1 Exp ENLIGHTENMENT CAPITAL 37316 37216 K-1 Exp FIRST EAGLE CLO EQUITY 8607 8607 K-1 Exp FOURTHSTONE SMALL-CAP 6117 6117 K-1 Exp GRANITE CREEK FLEXCAP 8190 8070 K-1 Exp GSO CAPITAL SOLUTIONS 2540 -14 K-1 Exp GSO CAPITAL SOLUTIONS 2050 2050 K-1 Exp GSO ENERGY SELECT OPPO 17700 1643 K-1 Exp GSO ENERGY SELECT OPPO 955 854 K-1 Exp GSO ENERGY SELECT OPPO 122 122 K-1 Exp GSO ENERGY SELECT OPPO 646 646 K-1 Exp PCCP EQUITY VII, LP 34364 34283 K-1 Exp PCCP EQUITY VIII, LP 5671 5663 K-1 Exp QS CAPITAL STRATEGIES 71205 71175 K-1 Exp SILVERVIEW CREDIT OPPO 2147 2147 K-1 Exp THE EDGBASTON ASIAN EQ 5201 4920 PARKING FEES 3180 3180 OFFICE SUPPLIES 5708 5708 Postage/Delivery Service 68 68 Registered Agent Fee 125 125 State or Local Filing Fees 250 250 Website Hosting/Support 576 576 K-1 Inc/Loss AIR U.S. LIFE FUND III, LP 51 51 K-1 Inc/Loss AIR US LIFE FUND IV, LP 71 71 K-1 Inc/Loss ALTAIR - PACIFIC COAST CPTL PTNRS EQ -9724 -6856 K-1 Inc/Loss ALTAIR DIRECT LENDING FUND, LLC 461 461 K-1 Inc/Loss ALTAIR SENIOR HOUSING FUND (AEW), LL -24794 -549 K-1 Inc/Loss ANAGENESIS CAPITAL PARTNERS SBIC FUN 227787 281248 K-1 Inc/Loss AVANTE CAPITAL PARTNERS SBIC III, LP 47540 44641 K-1 Inc/Loss BW GAS & CONVENIENCE ONSHORE FUND, L -248550 K-1 Inc/Loss ENLIGHTENMENT CAPITAL SOLUTIONS FUND 157552 130810 K-1 Inc/Loss ENLIGHTENMENT CAPITAL SOLUTIONS FUND 18743 10286 K-1 Inc/Loss FIRST EAGLE CLO EQUITY FUND I, LP 42210 42210 K-1 Inc/Loss FOURTHSTONE SMALL-CAP FINANCIALS FD 6573 5939 K-1 Inc/Loss GRANITE CREEK FLEXCAP II, L.P 60368 60368 K-1 Inc/Loss GSO CAPITAL SOLUTIONS FUND II AIV-1 -19 -19 K-1 Inc/Loss GSO CAPITAL SOLUTIONS FUND II AIV-2 -10435 8 K-1 Inc/Loss GSO CAPITAL SOLUTIONS FUND II LP 26906 26857 K-1 Inc/Loss GSO ENERGY SELECT OPPORTUNITIES FUND 26282 81 K-1 Inc/Loss GSO ENERGY SELECT OPPORTUNITIES FUND 9 8 K-1 Inc/Loss PCCP EQUITY VII, LP 132484 38657 K-1 Inc/Loss PCCP EQUITY VIII, LP -11146 1706 K-1 Inc/Loss QS CAPITAL STRATEGIES II, L.P 81245 111556 K-1 Inc/Loss SILVERVIEW CREDIT OPPORTUNITES OFFSH 138430 138430 K-1 Inc/Loss THE EDGBASTON ASIAN EQUITY TRUST 67191 67191 Federal Tax Refund 117578 Foreign Currency Loss -1254 -1254 State Tax Refund 38051 RETURNED GRANT 1000 PROGRAMMER SERVICES 1000 1000 EMPLOYEE RECRUITING SERVICES 32500 32500 Investment Management Services 409834 409834 DESIGNER SERVICES 3000 3000 Philanthropic Consulting Srvcs 101600 101600 PROJECT MANAGEMENT SERVICES 1000 1000 PHOTO SERVICES 500 500 VIDEO PRODUCTION 12136 12136 990-PF Estimated Tax for 2022 41900 990-T Extension for 2021 70100 990-T Income Tax for 2021 1104 Foreign Tax Paid 17659 17659 IRS MISCELLANEOUS FEE 9 STATE INCOME TAX 2021 31100